The MAPLe® wins the award for the most innovative medical device during the MEDICA

23/11/2016

The MEDICA in Düsseldorf – this year from 14-18 November – is the world’s leading trade fair for the medical industry. The Netherlands Business Support Office (NBSO) organized a lunch session, ‘Neues aus dem Nachbarland: Medical Device Pitches’, with, amongst others, the consul-general in Düsseldorf Ton Lansing, to bring Dutch and German medtech companies together.

There were pitches of three Dutch and three German medtech companies, including the Dutch team Novuqare and TOPIC Embedded Systems. These pitches were assessed by a Dutch/German jury.

Novuqare and TOPIC pitched about the MAPLe®, the most innovative EMG system for the diagnosis and treatment of pelvic floor dysfunctions.  

The pitch of Fiebke Op de Macks, Novuqare:

A targeted and effective treatment of pelvic floor dysfunctions starts with an accurate diagnosis. With the MAPLe technology you can see the EMG activity of the individual pelvic floor muscles at a glance. This allows practitioners to give a targeted treatment and patients are more aware of where the problem in the pelvic floor is.  

The pitch of Eric van der Laak, TOPIC Embedded Systems:

Novuqare was looking for an innovative product developer. That had to be a partner who would be able to respond adequately to changes in the development resulting from experiences gained during clinical trials. TOPIC Embedded Systems is that development partner and unburdens Novuqare by using its innovative solutions (e.g. Dyplo) and certified knowledge of medical device development. Resulting in a rapid development from concept development to market launch.

After having answered some critical questions from Dr. Ralf Kindervater (BIOPROD Baden-Württemberg GmbH), team Novuqare/Topic was announced as the winner!

Fiebke Op de Macks, Manager R&D / Business Developer at Novuqare comments:
“We just started the roll-out of the MAPLe in Germany and the market response is very positive. Winning this pitch and getting the publicity, will help us to further expand the introduction of the MAPLe in the German market.”              

Formulaire de contact Envoyer un courriel

Conditions générales Novuqare Pelvic Health B.V.

Travailler chez Novuqare